Tirzepatide is FDA approved and available now, while retatrutide is still in clinical trials
It is marketed as Ozempic (injectable, diabetes), Wegovy (injectable, obesity), and Rybelsus (oral, with SNAC absorption enhancer)
Twenty-four boasted improved energy, and a good number felt more empowered to engage in exercise
While many people focus solely on cardio for weight loss, combining it with strength training offers a more well-rounded approach to improving your body composition and breaking through plateaus
Ongoing use can help sustain weight loss and support metabolic health, provided any side effects are properly managed with professional guidance
Period changes may not always be linked to weight loss or GLP-1 injections, they could be caused by something else